Question 1

What are the potential side effects of WEF-001?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. clinical trial (NCT07148128). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. clinical trial (NCT07148128). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. clinical trial (NCT07148128). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or monitoring I will need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. clinical trial (NCT07148128). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. clinical trial (NCT07148128). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be evaluated during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. clinical trial (NCT07148128). Contact the study team or your healthcare provider for specific answers.

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

What this study is about

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

What this study is about